EPRX fundamentals

An in-depth look to EUPRAXIA PHARMACEUTICALS INC operating, investing, and financing activities

EPRX free cash flow for Q4 24 is -8.51 M CAD. For 2024, EPRX free cash flow was -41.23 M CAD and operating cash flow was -41.09 M CAD.

Q3 '19

Q4 '19

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: CAD